Share Price and Basic Stock Data
Last Updated: December 13, 2025, 9:02 am
| PEG Ratio | -6.33 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Sudarshan Chemical Industries Ltd operates in the dyes and pigments sector, an industry that has seen varying fortunes over the years. For the fiscal year ended March 2025, the company reported revenues of ₹3,346 Cr, marking a significant rise from ₹2,539 Cr in the previous year. This upward trajectory is indicative of a robust demand for its products, likely driven by the revival in manufacturing and export activities post-pandemic. Quarter-on-quarter analysis shows that revenue surged to ₹1,349.44 Cr in March 2025 from ₹691.18 Cr in March 2023, highlighting a strong recovery. However, the operating profit margin (OPM) for March 2025 stood at 9.41%, which reflects the challenges the company faces in managing costs amid fluctuating raw material prices. Overall, while revenue growth appears strong, maintaining profitability in a competitive landscape remains a concern.
Profitability and Efficiency Metrics
When assessing Sudarshan’s profitability, the numbers reveal a mixed performance. The net profit for March 2025 was reported at just ₹0.31 Cr, a stark drop from ₹58.03 Cr in March 2024, which raises questions about the company’s ability to convert sales into profit efficiently. The return on equity (ROE) and return on capital employed (ROCE) are relatively low at 3.07% and 6.03%, respectively, suggesting that the company is not maximizing its capital effectively. Additionally, the interest coverage ratio (ICR) stands at a comfortable 8.58x, indicating that the company can cover its interest obligations without much strain. However, the cash conversion cycle (CCC) has ballooned to 353 days, reflecting inefficiencies in managing inventory and receivables that could further squeeze profitability if not addressed.
Balance Sheet Strength and Financial Ratios
The balance sheet of Sudarshan Chemical exhibits a mix of strengths and vulnerabilities. As of March 2025, total borrowings stood at ₹2,528 Cr, a significant increase from ₹467 Cr in March 2024, raising concerns about financial leverage. However, the company also reported reserves of ₹3,504 Cr, which suggests a solid buffer against economic downturns. The current ratio is healthy at 2.12x, indicating that the company can meet its short-term liabilities comfortably. Nonetheless, the price-to-book value ratio (P/BV) of 2.26x suggests that the stock may be overvalued relative to its book value, especially given the low profitability metrics. Investors should consider these financial ratios to gauge the company’s long-term sustainability and ability to weather economic challenges.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sudarshan Chemical reveals a notable shift in investor confidence. Promoter holdings have declined from 35.82% in March 2023 to just 8.20% in September 2025, which could indicate a lack of confidence in the company’s future prospects. On the other hand, institutional investors, particularly domestic institutions (DIIs), have increased their stake to 24.17%, reflecting a belief in the company’s potential amidst its challenges. The public holding has also risen to 59.08%, suggesting that retail investors are now taking a more significant interest. This dynamic could be a double-edged sword; while increasing public interest might stabilize the stock, the declining promoter stake could raise red flags about the management’s confidence in future performance.
Outlook, Risks, and Final Insight
Looking ahead, Sudarshan Chemical faces a landscape filled with both opportunities and risks. The recovery in global manufacturing could provide a tailwind for revenue growth, but the challenges of maintaining profitability amidst rising costs and inefficiencies in operations cannot be overlooked. Investors should be cautious about the declining promoter stake, which may signal underlying issues in management confidence. Additionally, the high cash conversion cycle poses a risk to liquidity, especially if market conditions become unfavorable. Overall, while the stock may appeal to those looking for growth in a recovering sector, potential investors should weigh these risks carefully against the company’s financial health and operational efficiency before making decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dynamic Industries Ltd | 37.7 Cr. | 124 | 190/68.5 | 20.7 | 162 | 0.80 % | 5.68 % | 3.39 % | 10.0 |
| Daikaffil Chemicals India Ltd | 43.2 Cr. | 72.1 | 281/70.0 | 13.2 | 0.00 % | 18.6 % | 18.6 % | 10.0 | |
| Amal Ltd | 794 Cr. | 642 | 1,148/412 | 20.5 | 91.7 | 0.16 % | 36.3 % | 35.0 % | 10.0 |
| Vidhi Specialty Food Ingredients Ltd | 1,647 Cr. | 330 | 572/272 | 34.2 | 62.2 | 1.52 % | 18.7 % | 14.9 % | 1.00 |
| Ushanti Colour Chem Ltd | 53.9 Cr. | 48.0 | 67.1/38.0 | 37.7 | 0.00 % | 0.98 % | 5.98 % | 10.0 | |
| Industry Average | 1,343.92 Cr | 296.59 | 95.84 | 186.93 | 0.40% | 11.00% | 9.10% | 8.13 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 627.15 | 554.16 | 528.38 | 528.02 | 691.18 | 608.11 | 600.68 | 565.75 | 764.24 | 633.62 | 696.09 | 666.43 | 1,349.44 |
| Expenses | 541.07 | 512.74 | 485.51 | 486.38 | 606.46 | 538.23 | 535.10 | 503.88 | 645.16 | 553.05 | 601.60 | 587.44 | 1,222.45 |
| Operating Profit | 86.08 | 41.42 | 42.87 | 41.64 | 84.72 | 69.88 | 65.58 | 61.87 | 119.08 | 80.57 | 94.49 | 78.99 | 126.99 |
| OPM % | 13.73% | 7.47% | 8.11% | 7.89% | 12.26% | 11.49% | 10.92% | 10.94% | 15.58% | 12.72% | 13.57% | 11.85% | 9.41% |
| Other Income | 1.71 | 0.84 | 1.42 | 0.99 | 1.54 | 319.24 | 5.69 | 4.28 | 2.99 | 3.50 | -6.19 | -26.34 | -38.33 |
| Interest | 5.46 | 6.06 | 9.34 | 11.02 | 15.05 | 10.31 | 9.63 | 8.58 | 8.38 | 7.03 | 8.88 | 11.41 | 20.96 |
| Depreciation | 24.80 | 25.80 | 26.95 | 30.91 | 30.56 | 34.60 | 35.42 | 35.48 | 35.67 | 35.93 | 36.61 | 36.55 | 57.14 |
| Profit before tax | 57.53 | 10.40 | 8.00 | 0.70 | 40.65 | 344.21 | 26.22 | 22.09 | 78.02 | 41.11 | 42.81 | 4.69 | 10.56 |
| Tax % | 22.37% | 31.92% | 43.25% | 17.14% | 19.85% | 22.44% | 31.88% | 33.91% | 25.61% | 28.39% | 30.13% | 89.13% | 97.06% |
| Net Profit | 44.66 | 7.08 | 4.54 | 0.58 | 32.57 | 266.96 | 17.86 | 14.59 | 58.03 | 29.43 | 29.90 | 0.51 | 0.31 |
| EPS in Rs | 6.45 | 1.02 | 0.66 | 0.08 | 4.70 | 38.56 | 2.58 | 2.11 | 8.38 | 4.25 | 4.32 | 0.07 | -0.52 |
Last Updated: August 1, 2025, 11:00 am
Below is a detailed analysis of the quarterly data for Sudarshan Chemical Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 1,349.44 Cr.. The value appears strong and on an upward trend. It has increased from 666.43 Cr. (Dec 2024) to 1,349.44 Cr., marking an increase of 683.01 Cr..
- For Expenses, as of Mar 2025, the value is 1,222.45 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 587.44 Cr. (Dec 2024) to 1,222.45 Cr., marking an increase of 635.01 Cr..
- For Operating Profit, as of Mar 2025, the value is 126.99 Cr.. The value appears strong and on an upward trend. It has increased from 78.99 Cr. (Dec 2024) to 126.99 Cr., marking an increase of 48.00 Cr..
- For OPM %, as of Mar 2025, the value is 9.41%. The value appears to be declining and may need further review. It has decreased from 11.85% (Dec 2024) to 9.41%, marking a decrease of 2.44%.
- For Other Income, as of Mar 2025, the value is -38.33 Cr.. The value appears to be declining and may need further review. It has decreased from -26.34 Cr. (Dec 2024) to -38.33 Cr., marking a decrease of 11.99 Cr..
- For Interest, as of Mar 2025, the value is 20.96 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.41 Cr. (Dec 2024) to 20.96 Cr., marking an increase of 9.55 Cr..
- For Depreciation, as of Mar 2025, the value is 57.14 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.55 Cr. (Dec 2024) to 57.14 Cr., marking an increase of 20.59 Cr..
- For Profit before tax, as of Mar 2025, the value is 10.56 Cr.. The value appears strong and on an upward trend. It has increased from 4.69 Cr. (Dec 2024) to 10.56 Cr., marking an increase of 5.87 Cr..
- For Tax %, as of Mar 2025, the value is 97.06%. The value appears to be increasing, which may not be favorable. It has increased from 89.13% (Dec 2024) to 97.06%, marking an increase of 7.93%.
- For Net Profit, as of Mar 2025, the value is 0.31 Cr.. The value appears to be declining and may need further review. It has decreased from 0.51 Cr. (Dec 2024) to 0.31 Cr., marking a decrease of 0.20 Cr..
- For EPS in Rs, as of Mar 2025, the value is -0.52. The value appears to be declining and may need further review. It has decreased from 0.07 (Dec 2024) to -0.52, marking a decrease of 0.59.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:22 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,106 | 1,205 | 1,401 | 1,282 | 1,329 | 1,593 | 1,708 | 1,864 | 2,201 | 2,302 | 2,539 | 3,346 | 5,219 |
| Expenses | 974 | 1,075 | 1,232 | 1,093 | 1,139 | 1,386 | 1,460 | 1,574 | 1,923 | 2,088 | 2,220 | 2,962 | 4,726 |
| Operating Profit | 133 | 131 | 170 | 189 | 191 | 207 | 248 | 290 | 278 | 213 | 318 | 383 | 493 |
| OPM % | 12% | 11% | 12% | 15% | 14% | 13% | 15% | 16% | 13% | 9% | 13% | 11% | 9% |
| Other Income | 2 | 23 | 14 | 25 | 15 | 81 | 22 | 7 | 5 | 5 | 332 | -67 | -38 |
| Interest | 43 | 41 | 37 | 30 | 25 | 19 | 16 | 20 | 23 | 44 | 39 | 51 | 85 |
| Depreciation | 37 | 42 | 48 | 49 | 58 | 66 | 74 | 87 | 89 | 114 | 141 | 166 | 229 |
| Profit before tax | 55 | 72 | 99 | 136 | 123 | 203 | 180 | 190 | 171 | 60 | 471 | 99 | 140 |
| Tax % | 37% | 24% | 29% | 25% | 31% | 33% | 20% | 26% | 24% | 25% | 24% | 39% | |
| Net Profit | 35 | 54 | 70 | 101 | 85 | 135 | 145 | 141 | 130 | 45 | 357 | 60 | 86 |
| EPS in Rs | 5.08 | 7.86 | 10.10 | 14.64 | 12.24 | 19.52 | 20.88 | 20.38 | 18.77 | 6.47 | 51.63 | 7.10 | 9.88 |
| Dividend Payout % | 30% | 22% | 30% | 24% | 29% | 31% | 30% | 29% | 27% | 23% | 9% | 63% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 54.29% | 29.63% | 44.29% | -15.84% | 58.82% | 7.41% | -2.76% | -7.80% | -65.38% | 693.33% | -83.19% |
| Change in YoY Net Profit Growth (%) | 0.00% | -24.66% | 14.66% | -60.13% | 74.67% | -51.42% | -10.17% | -5.04% | -57.58% | 758.72% | -776.53% |
Sudarshan Chemical Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 14% |
| 3 Years: | 15% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -11% |
| 3 Years: | -18% |
| TTM: | -35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 26% |
| 3 Years: | 46% |
| 1 Year: | 36% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:36 pm
Balance Sheet
Last Updated: December 4, 2025, 2:02 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 16 | 16 |
| Reserves | 264 | 249 | 300 | 367 | 426 | 554 | 587 | 730 | 819 | 814 | 1,135 | 3,424 | 3,504 |
| Borrowings | 440 | 433 | 430 | 433 | 431 | 367 | 501 | 618 | 823 | 829 | 467 | 2,378 | 2,528 |
| Other Liabilities | 217 | 317 | 346 | 379 | 433 | 424 | 522 | 638 | 705 | 725 | 730 | 3,854 | 3,706 |
| Total Liabilities | 929 | 1,012 | 1,090 | 1,193 | 1,304 | 1,358 | 1,624 | 2,000 | 2,361 | 2,383 | 2,346 | 9,672 | 9,754 |
| Fixed Assets | 327 | 333 | 358 | 452 | 475 | 465 | 627 | 615 | 832 | 1,126 | 1,102 | 2,958 | 3,057 |
| CWIP | 7 | 8 | 15 | 8 | 6 | 24 | 48 | 278 | 285 | 44 | 15 | 140 | 159 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 548 | 539 |
| Other Assets | 594 | 671 | 716 | 733 | 822 | 869 | 948 | 1,105 | 1,243 | 1,210 | 1,227 | 6,026 | 5,999 |
| Total Assets | 929 | 1,012 | 1,090 | 1,193 | 1,304 | 1,358 | 1,624 | 2,000 | 2,361 | 2,383 | 2,346 | 9,672 | 9,754 |
Below is a detailed analysis of the balance sheet data for Sudarshan Chemical Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,504.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,424.00 Cr. (Mar 2025) to 3,504.00 Cr., marking an increase of 80.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2,528.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2,378.00 Cr. (Mar 2025) to 2,528.00 Cr., marking an increase of 150.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3,706.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3,854.00 Cr. (Mar 2025) to 3,706.00 Cr., marking a decrease of 148.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 9,754.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,672.00 Cr. (Mar 2025) to 9,754.00 Cr., marking an increase of 82.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3,057.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,958.00 Cr. (Mar 2025) to 3,057.00 Cr., marking an increase of 99.00 Cr..
- For CWIP, as of Sep 2025, the value is 159.00 Cr.. The value appears strong and on an upward trend. It has increased from 140.00 Cr. (Mar 2025) to 159.00 Cr., marking an increase of 19.00 Cr..
- For Investments, as of Sep 2025, the value is 539.00 Cr.. The value appears to be declining and may need further review. It has decreased from 548.00 Cr. (Mar 2025) to 539.00 Cr., marking a decrease of 9.00 Cr..
- For Other Assets, as of Sep 2025, the value is 5,999.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6,026.00 Cr. (Mar 2025) to 5,999.00 Cr., marking a decrease of 27.00 Cr..
- For Total Assets, as of Sep 2025, the value is 9,754.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,672.00 Cr. (Mar 2025) to 9,754.00 Cr., marking an increase of 82.00 Cr..
Notably, the Reserves (3,504.00 Cr.) exceed the Borrowings (2,528.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -307.00 | -302.00 | -260.00 | -244.00 | -240.00 | -160.00 | -253.00 | -328.00 | -545.00 | -616.00 | -149.00 | 381.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 85 | 96 | 92 | 98 | 92 | 79 | 78 | 95 | 83 | 77 | 84 | 134 |
| Inventory Days | 144 | 125 | 113 | 134 | 131 | 119 | 154 | 142 | 163 | 132 | 113 | 507 |
| Days Payable | 63 | 94 | 96 | 139 | 126 | 94 | 139 | 152 | 150 | 136 | 132 | 288 |
| Cash Conversion Cycle | 166 | 127 | 109 | 93 | 96 | 105 | 92 | 85 | 96 | 73 | 65 | 353 |
| Working Capital Days | 41 | 26 | 40 | 14 | 43 | 51 | 24 | 29 | 18 | 23 | 40 | 154 |
| ROCE % | 14% | 16% | 19% | 22% | 18% | 17% | 18% | 17% | 13% | 6% | 11% | 6% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Small Cap Fund | 5,789,852 | 1.73 | 665.72 | N/A | N/A | N/A |
| Tata Small Cap Fund | 4,691,125 | 4.57 | 539.39 | N/A | N/A | N/A |
| Axis Small Cap Fund | 1,945,414 | 0.83 | 223.68 | 2,440,688 | 2025-12-08 01:00:56 | -20.29% |
| Franklin India Opportunities Fund | 1,431,787 | 2.01 | 164.63 | N/A | N/A | N/A |
| Nippon India Small Cap Fund | 1,083,578 | 0.18 | 124.59 | N/A | N/A | N/A |
| Tata Large & Mid Cap Fund | 973,769 | 1.27 | 111.96 | N/A | N/A | N/A |
| DSP Small Cap Fund | 640,000 | 0.44 | 73.59 | N/A | N/A | N/A |
| ICICI Prudential Commodities Fund | 14,788 | 0.05 | 1.7 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 22.50 | 51.60 | 6.50 | 18.80 | 20.40 |
| Diluted EPS (Rs.) | 22.50 | 51.60 | 6.50 | 18.70 | 20.40 |
| Cash EPS (Rs.) | 28.45 | 72.03 | 22.97 | 31.67 | 32.88 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 437.80 | 165.99 | 119.64 | 120.36 | 107.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 437.80 | 165.99 | 119.64 | 120.36 | 107.41 |
| Revenue From Operations / Share (Rs.) | 425.78 | 366.74 | 332.50 | 317.92 | 269.28 |
| PBDIT / Share (Rs.) | 52.74 | 48.18 | 31.12 | 40.42 | 42.58 |
| PBIT / Share (Rs.) | 31.59 | 27.78 | 14.62 | 27.53 | 30.08 |
| PBT / Share (Rs.) | 12.26 | 67.97 | 8.63 | 24.72 | 27.50 |
| Net Profit / Share (Rs.) | 7.29 | 51.64 | 6.47 | 18.77 | 20.38 |
| NP After MI And SOA / Share (Rs.) | 7.10 | 51.64 | 6.47 | 18.77 | 20.38 |
| PBDIT Margin (%) | 12.38 | 13.13 | 9.35 | 12.71 | 15.81 |
| PBIT Margin (%) | 7.41 | 7.57 | 4.39 | 8.65 | 11.17 |
| PBT Margin (%) | 2.87 | 18.53 | 2.59 | 7.77 | 10.21 |
| Net Profit Margin (%) | 1.71 | 14.07 | 1.94 | 5.90 | 7.56 |
| NP After MI And SOA Margin (%) | 1.66 | 14.07 | 1.94 | 5.90 | 7.56 |
| Return on Networth / Equity (%) | 1.62 | 31.10 | 5.40 | 15.59 | 18.97 |
| Return on Capital Employeed (%) | 3.64 | 12.88 | 7.23 | 14.59 | 18.20 |
| Return On Assets (%) | 0.57 | 15.17 | 1.87 | 5.48 | 7.04 |
| Long Term Debt / Equity (X) | 0.47 | 0.16 | 0.54 | 0.44 | 0.41 |
| Total Debt / Equity (X) | 0.60 | 0.38 | 0.98 | 0.98 | 0.65 |
| Asset Turnover Ratio (%) | 0.55 | 1.07 | 0.87 | 0.90 | 0.96 |
| Current Ratio (X) | 2.12 | 1.38 | 1.17 | 1.13 | 1.20 |
| Quick Ratio (X) | 1.27 | 0.87 | 0.67 | 0.60 | 0.72 |
| Inventory Turnover Ratio (X) | 2.31 | 2.96 | 2.48 | 2.82 | 2.64 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 9.87 | 77.31 | 31.95 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 7.08 | 21.77 | 18.94 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 90.13 | 22.69 | 68.05 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 92.92 | 78.23 | 81.06 | 0.00 |
| Interest Coverage Ratio (X) | 8.58 | 9.04 | 5.19 | 14.41 | 16.49 |
| Interest Coverage Ratio (Post Tax) (X) | 4.33 | 2.15 | 2.08 | 7.69 | 8.90 |
| Enterprise Value (Cr.) | 8962.37 | 4605.33 | 3488.90 | 4384.53 | 4055.41 |
| EV / Net Operating Revenue (X) | 2.68 | 1.81 | 1.52 | 1.99 | 2.18 |
| EV / EBITDA (X) | 21.63 | 13.81 | 16.19 | 15.67 | 13.76 |
| MarketCap / Net Operating Revenue (X) | 2.33 | 1.66 | 1.17 | 1.64 | 1.93 |
| Retention Ratios (%) | 0.00 | 90.12 | 22.68 | 68.04 | 0.00 |
| Price / BV (X) | 2.26 | 3.67 | 3.26 | 4.32 | 4.83 |
| Price / Net Operating Revenue (X) | 2.33 | 1.66 | 1.17 | 1.64 | 1.93 |
| EarningsYield | 0.01 | 0.08 | 0.01 | 0.03 | 0.03 |
After reviewing the key financial ratios for Sudarshan Chemical Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 22.50. This value is within the healthy range. It has decreased from 51.60 (Mar 24) to 22.50, marking a decrease of 29.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is 22.50. This value is within the healthy range. It has decreased from 51.60 (Mar 24) to 22.50, marking a decrease of 29.10.
- For Cash EPS (Rs.), as of Mar 25, the value is 28.45. This value is within the healthy range. It has decreased from 72.03 (Mar 24) to 28.45, marking a decrease of 43.58.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 437.80. It has increased from 165.99 (Mar 24) to 437.80, marking an increase of 271.81.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 437.80. It has increased from 165.99 (Mar 24) to 437.80, marking an increase of 271.81.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 425.78. It has increased from 366.74 (Mar 24) to 425.78, marking an increase of 59.04.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 52.74. This value is within the healthy range. It has increased from 48.18 (Mar 24) to 52.74, marking an increase of 4.56.
- For PBIT / Share (Rs.), as of Mar 25, the value is 31.59. This value is within the healthy range. It has increased from 27.78 (Mar 24) to 31.59, marking an increase of 3.81.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.26. This value is within the healthy range. It has decreased from 67.97 (Mar 24) to 12.26, marking a decrease of 55.71.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 7.29. This value is within the healthy range. It has decreased from 51.64 (Mar 24) to 7.29, marking a decrease of 44.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.10. This value is within the healthy range. It has decreased from 51.64 (Mar 24) to 7.10, marking a decrease of 44.54.
- For PBDIT Margin (%), as of Mar 25, the value is 12.38. This value is within the healthy range. It has decreased from 13.13 (Mar 24) to 12.38, marking a decrease of 0.75.
- For PBIT Margin (%), as of Mar 25, the value is 7.41. This value is below the healthy minimum of 10. It has decreased from 7.57 (Mar 24) to 7.41, marking a decrease of 0.16.
- For PBT Margin (%), as of Mar 25, the value is 2.87. This value is below the healthy minimum of 10. It has decreased from 18.53 (Mar 24) to 2.87, marking a decrease of 15.66.
- For Net Profit Margin (%), as of Mar 25, the value is 1.71. This value is below the healthy minimum of 5. It has decreased from 14.07 (Mar 24) to 1.71, marking a decrease of 12.36.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.66. This value is below the healthy minimum of 8. It has decreased from 14.07 (Mar 24) to 1.66, marking a decrease of 12.41.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.62. This value is below the healthy minimum of 15. It has decreased from 31.10 (Mar 24) to 1.62, marking a decrease of 29.48.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.64. This value is below the healthy minimum of 10. It has decreased from 12.88 (Mar 24) to 3.64, marking a decrease of 9.24.
- For Return On Assets (%), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 5. It has decreased from 15.17 (Mar 24) to 0.57, marking a decrease of 14.60.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.47. This value is within the healthy range. It has increased from 0.16 (Mar 24) to 0.47, marking an increase of 0.31.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.60. This value is within the healthy range. It has increased from 0.38 (Mar 24) to 0.60, marking an increase of 0.22.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.55. It has decreased from 1.07 (Mar 24) to 0.55, marking a decrease of 0.52.
- For Current Ratio (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has increased from 1.38 (Mar 24) to 2.12, marking an increase of 0.74.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 0.87 (Mar 24) to 1.27, marking an increase of 0.40.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 4. It has decreased from 2.96 (Mar 24) to 2.31, marking a decrease of 0.65.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 9.87 (Mar 24) to 0.00, marking a decrease of 9.87.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 7.08 (Mar 24) to 0.00, marking a decrease of 7.08.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 90.13 (Mar 24) to 0.00, marking a decrease of 90.13.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.92 (Mar 24) to 0.00, marking a decrease of 92.92.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.58. This value is within the healthy range. It has decreased from 9.04 (Mar 24) to 8.58, marking a decrease of 0.46.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.33. This value is within the healthy range. It has increased from 2.15 (Mar 24) to 4.33, marking an increase of 2.18.
- For Enterprise Value (Cr.), as of Mar 25, the value is 8,962.37. It has increased from 4,605.33 (Mar 24) to 8,962.37, marking an increase of 4,357.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.68. This value is within the healthy range. It has increased from 1.81 (Mar 24) to 2.68, marking an increase of 0.87.
- For EV / EBITDA (X), as of Mar 25, the value is 21.63. This value exceeds the healthy maximum of 15. It has increased from 13.81 (Mar 24) to 21.63, marking an increase of 7.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.33. This value is within the healthy range. It has increased from 1.66 (Mar 24) to 2.33, marking an increase of 0.67.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 90.12 (Mar 24) to 0.00, marking a decrease of 90.12.
- For Price / BV (X), as of Mar 25, the value is 2.26. This value is within the healthy range. It has decreased from 3.67 (Mar 24) to 2.26, marking a decrease of 1.41.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.33. This value is within the healthy range. It has increased from 1.66 (Mar 24) to 2.33, marking an increase of 0.67.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 24) to 0.01, marking a decrease of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sudarshan Chemical Industries Ltd:
- Net Profit Margin: 1.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.64% (Industry Average ROCE: 11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.62% (Industry Average ROE: 9.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.33
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 76.3 (Industry average Stock P/E: 95.84)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.6
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | 7th Floor, Eleven West Panchshil, Pune Maharashtra 411045 | grievance.redressal@sudarshan.com http://www.sudarshan.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rajesh B Rathi | Chairman & Managing Director |
| Mr. Ashish Vij | Whole Time Director |
| Mr. Naresh T Raisinghani | Ind. Non-Executive Director |
| Mrs. Shubhalakshmi A Panse | Ind. Non-Executive Director |
| Mrs. Anu A Wakhlu | Ind. Non-Executive Director |
| Mrs. Sudha P Navandar | Ind. Non-Executive Director |
| Ms. Bhumika Batra | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Sudarshan Chemical Industries Ltd?
Sudarshan Chemical Industries Ltd's intrinsic value (as of 14 December 2025) is 843.30 which is 15.33% lower the current market price of 996.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 7,833 Cr. market cap, FY2025-2026 high/low of 1,604/796, reserves of ₹3,504 Cr, and liabilities of 9,754 Cr.
What is the Market Cap of Sudarshan Chemical Industries Ltd?
The Market Cap of Sudarshan Chemical Industries Ltd is 7,833 Cr..
What is the current Stock Price of Sudarshan Chemical Industries Ltd as on 14 December 2025?
The current stock price of Sudarshan Chemical Industries Ltd as on 14 December 2025 is 996.
What is the High / Low of Sudarshan Chemical Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sudarshan Chemical Industries Ltd stocks is 1,604/796.
What is the Stock P/E of Sudarshan Chemical Industries Ltd?
The Stock P/E of Sudarshan Chemical Industries Ltd is 76.3.
What is the Book Value of Sudarshan Chemical Industries Ltd?
The Book Value of Sudarshan Chemical Industries Ltd is 448.
What is the Dividend Yield of Sudarshan Chemical Industries Ltd?
The Dividend Yield of Sudarshan Chemical Industries Ltd is 0.45 %.
What is the ROCE of Sudarshan Chemical Industries Ltd?
The ROCE of Sudarshan Chemical Industries Ltd is 6.03 %.
What is the ROE of Sudarshan Chemical Industries Ltd?
The ROE of Sudarshan Chemical Industries Ltd is 3.07 %.
What is the Face Value of Sudarshan Chemical Industries Ltd?
The Face Value of Sudarshan Chemical Industries Ltd is 2.00.